We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $3.85B
1-Year Est. Return 32.11%
This Fund
S&P 500
This Quarter Est. Return
+1.72%
1 Year Est. Return
+32.11%
3 Year Est. Return
+93.86%
5 Year Est. Return
+112.79%
10 Year Est. Return
+380.9%
AUM
$780M
AUM Growth
+$181M
Cap. Flow
+$169M
Cap. Flow %
21.69%
Top 10 Hldgs %
29%
Holding
5,646
New
1,097
Increased
1,409
Reduced
2,025
Closed
1,047

Sector Composition

Rank Sector Weight
1 Financials 7.89%
2 Industrials 5.11%
3 Technology 4.56%
4 Energy 4.21%
5 Healthcare 3.63%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
UONE icon
2726
Urban One Class A
UONE
$23.8M
$9K ﹤0.01%
190
+17
+10% +$856
VALU icon
2727
Value Line
VALU
$361M
$9K ﹤0.01%
603
+361
+149% +$4.98K
LUMO
2728
DELISTED
Lumos Pharma, Inc. Common Stock
LUMO
$9K ﹤0.01%
33
-234
-88% -$71.5K
ALIM
2729
DELISTED
Alimera Sciences
ALIM
$9K ﹤0.01%
72
-27
-27% -$2.62K
NTG
2730
DELISTED
Tortoise Midstream Energy Fund, Inc. Common Stock
NTG
$9K ﹤0.01%
+34
New +$9.17K
MARK
2731
DELISTED
Remark Holdings, Inc.
MARK
$9K ﹤0.01%
163
-549
-77% -$30.5K
AENZ
2732
DELISTED
Aenza S.A.A.
AENZ
$9K ﹤0.01%
169
-2,016
-92% -$119K
SAL
2733
DELISTED
Salisbury Bancorp, Inc.
SAL
$9K ﹤0.01%
658
-1,514
-70% -$20.4K
USAK
2734
DELISTED
USA Truck Inc
USAK
$9K ﹤0.01%
613
+437
+248% +$6.25K
FMBI
2735
DELISTED
First Midwest Bancorp Inc/IL
FMBI
$9K ﹤0.01%
550
-482
-47% -$8.11K
KIN
2736
DELISTED
Kindred Biosciences, Inc.
KIN
$9K ﹤0.01%
502
-4,416
-90% -$84.2K
AMRB
2737
DELISTED
American River Bankshares
AMRB
$9K ﹤0.01%
992
+392
+65% +$3.82K
MNTA
2738
DELISTED
Momenta Pharmaceuticals, Inc.
MNTA
$9K ﹤0.01%
745
+9
+1% +$152
ALO
2739
DELISTED
Alio Gold Inc
ALO
$9K ﹤0.01%
717
+267
+59% +$3.66K
CSS
2740
DELISTED
CSS Industries, Inc.
CSS
$9K ﹤0.01%
312
-1,086
-78% -$29.6K
MDCO
2741
DELISTED
Medicines Co
MDCO
$9K ﹤0.01%
+319
New +$10.6K
MIDZ
2742
DELISTED
Direxion Daily Mid Cap Bear 3X Shares
MIDZ
$9K ﹤0.01%
+26
New +$9.2K
SIFI
2743
DELISTED
SI Financial Group, Inc. NEW MD
SIFI
$9K ﹤0.01%
742
-1,085
-59% -$12.7K
APF
2744
DELISTED
Morgan Stanley Asia Pacific Fund
APF
$9K ﹤0.01%
+504
New +$8.19K
AGC
2745
DELISTED
Advent Claymore Conv Sec & Incme
AGC
$9K ﹤0.01%
1,167
+167
+17% +$1.27K
CBF
2746
DELISTED
Capital Bank Financial Corp. Class A Common Stock
CBF
$9K ﹤0.01%
360
-824
-70% -$19.4K
SEV
2747
DELISTED
Sevcon, Inc.
SEV
$9K ﹤0.01%
820
+687
+517% +$6.86K
MACK
2748
DELISTED
Merrimack Pharmaceuticals, Inc.
MACK
$9K ﹤0.01%
236
+166
+237% +$7.1K
IPF
2749
DELISTED
SPDR S&P International Financial Sector
IPF
$9K ﹤0.01%
+400
New +$8.97K
KCG
2750
DELISTED
KCG Holdings, Inc.
KCG
$9K ﹤0.01%
+785
New +$9.27K

Similar funds

Tower Research Capital (TRC)'s Q1 2014 Portfolio in Review

As of Q1 2014, Tower Research Capital (TRC) held 5,646 positions worth $780M, up 30% from $599M the previous quarter. Its ten largest holdings account for 29% of the portfolio.

Tower Research Capital (TRC) deployed $169M of net new capital in Q1 2014, opening 1,097 new positions and adding to 1,409 existing holdings. Its largest new stake was iShares US Real Estate ETF: 131,900 shares worth $8.93M.

By sector, the portfolio is most concentrated in Financials at 7.9% of assets, down from 8% a quarter earlier, followed by Industrials and Technology.

On the sell side, the largest reduction was iShares Russell 2000 ETF, an estimated $40.7M trimmed.

  • Tower Research Capital (TRC)'s largest Q1 2014 buy was iShares US Real Estate ETF: 131,900 shares worth $8.93M.
  • Tower Research Capital (TRC) added most to Invesco QQQ Trust in Q1 2014, an estimated $111M increase.
  • Tower Research Capital (TRC)'s biggest Q1 2014 reduction was iShares Russell 2000 ETF, cutting an estimated $40.7M.
  • Tower Research Capital (TRC) fully exited State Street SPDR Dow Jones Industrial Average ETF Trust in Q1 2014, selling an estimated $8.86M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 29% of its $780M portfolio in Q1 2014.
  • Tower Research Capital (TRC) opened 1,097 new positions and closed 1,047 in Q1 2014.
  • Tower Research Capital (TRC)'s portfolio value rose 30% quarter-over-quarter to $780M.

Based on Tower Research Capital (TRC)'s 13F filing for Q1 2014, filed 2 May 2014.